Methods and compositions for treating and preventing anxiety and

Details Methods and compositions for treating and preventing anxiety and Methods and compositions for treating and preventing anxiety and

1999-10-27

2000-06-27

Henley, III, Raymond

Drug, bio-affecting and body treating compositions

Designated organic active ingredient containing

Heterocyclic carbon compounds containing a hetero ring...

A61K 315513

Patent

active

060807369

ABSTRACT:
Methods are disclosed utilizing the R enantiomer of tofisopam. This compound is useful in the treatment or prevention of anxiety or anxiety disorders while substantially reducing adverse effects associated with racemic tofisopam.

REFERENCES:
patent: 3736315 (1973-05-01), Korosi et al.
patent: 4423044 (1983-12-01), Korosi et al.
E. Fogassy et al., (1984) "Studies on the Properties and Structure of Optically Active 1-(3,4-Dimethoxyphenyl)-4-Methyl-5-Ethyl-7,8-Dimethoxy-5H-2,3-Benzodiazepi ne (Tofizopam)," Bio-Organic Heterocycles, van der Plas, H.C., Otvos L., and Simonyi, M., eds., pp. 229-233.
K. Imre et al., (1993) "A Tofizopam (Grandaxin.RTM.) Farmakokinetikaja es Metabolizmusa," Acta Pharmaccutica Hungarica 63:83-90.
P. Lujza, (1993) "A Tofizopam (Grandaxin.RTM.) Farmakologiai Hatasai," Acta Pharmaccutica Hungarica 63:79-82.
K. Maier et al., (1984) "The Effect of Tofisopam on Psychic Performance in Persons With More Than Average Anxiety: A Controlled Experimental Trial," Current Therapeutic Research 35(4):541-548.
F. Pal, (1993) "A Grandaxin.RTM. Gyogyszertechnologiaja," Acta Pharmaceutica Hungarica 63:67-78.
L. Petocz et al., (1975) "The Main Pharmacological Characteristics of Grandaxin (Tofizopam, EGYT-341)," Therp. Hungar. 23:134-138.
M. Simonyi et al., (1993) "Stereoselective Binding of a 2,3-Benzodiazepine to Human Serum Albumin," Biochemical Pharmacology 32(12):1917-1920.
R. Sladka et al., (1979) "A Placebo-controlled Clinical Trial With Tofizopam in the Treatment of Anxiety Neurosis," Ther. Hungar. 27:176-180.
G. Toth et al., (1983) "Racematspaltung von (.+-.)-5-Athyl-1-(3,4-dimethoxyphenyl)-6,7-dimethoxy-4-methyl-5H-2,3-benzo diazepin und anomales chiroptisches Verhalten der Enantiomeren (1)," J. Heterocyclic Chem. 20:709-713.
G. Varady et al., (1975) "The Clinical Evaluation of Grandaxin Used in the Treatment of Outpatients (A Multicentric Study)," Therap. Hungar. 23:153-158.
J. Visy et al., (1989) "The Role of Configuration and Conformation in the Binding of 2,3-Benzodiazepines to Human Serum Albumin," Chirality 1:271-275.

Affiliated with

Also associated with

Rating

Methods and compositions for treating and preventing anxiety and does not yet have a rating. At this time, there are no reviews or comments for this patent.

If you have personal experience with Methods and compositions for treating and preventing anxiety and, we encourage you to share that experience with our LandOfFree.com community. Your opinion is very important and Methods and compositions for treating and preventing anxiety and will most certainly appreciate the feedback.

Rate now

Comments { 0 }

Profile ID: LFUS-PAI-O-1784876